To explore the effect that glycosylation has on the quality of immune responses to YghJ, in this study we evaluate human systemic and gut anti-YghJ IgA antibody responses and the extent to which they actually target glycosylated epitopes of YghJ produced during infections with pathogenic E. coli. The gene discussed is CD79A; the disease is infection.